Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States
Although counts of the novel Coronavirus (SARS-CoV-2) infections and deaths are reported by several sources online, precise estimation of the exposed proportion of the population is not possible in most areas of the world. Estimates of other disease prevalence in the United States are often o...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Survey Research Association
2020-06-01
|
| Series: | Survey Research Methods |
| Subjects: | |
| Online Access: | https://ojs.ub.uni-konstanz.de/srm/article/view/7757 |
| _version_ | 1811319974137954304 |
|---|---|
| author | Alicia Frasier Heidi Guyer Laura DiGrande Rose Domanico Darryl Cooney Stephanie Eckman |
| author_facet | Alicia Frasier Heidi Guyer Laura DiGrande Rose Domanico Darryl Cooney Stephanie Eckman |
| author_sort | Alicia Frasier |
| collection | DOAJ |
| description |
Although counts of the novel Coronavirus (SARS-CoV-2) infections and deaths are reported by several sources online, precise estimation of the exposed proportion of the population is not possible in most areas of the world. Estimates of other disease prevalence in the United States are often obtained through in-person seroprevalence surveys. The availability of testing only for individuals with symptoms, combined with stay-at-home and social distancing mandates to stem the spread of the disease, limit in-person data collection options. A probability-based mail survey with at-home, self-administered testing is a feasible method to safely estimate SARS-CoV-2 antibody prevalence within the United States while also easing burden on the U.S. public and health care system. This mail survey could be a one-time, cross-sectional design, or a repeated cross-sectional or longitudinal survey. We discuss several options for designing and conducting this survey.
|
| first_indexed | 2024-04-13T12:52:24Z |
| format | Article |
| id | doaj.art-cc4b2fb7839e4736a27d65bd307cc291 |
| institution | Directory Open Access Journal |
| issn | 1864-3361 |
| language | English |
| last_indexed | 2024-04-13T12:52:24Z |
| publishDate | 2020-06-01 |
| publisher | European Survey Research Association |
| record_format | Article |
| series | Survey Research Methods |
| spelling | doaj.art-cc4b2fb7839e4736a27d65bd307cc2912022-12-22T02:46:11ZengEuropean Survey Research AssociationSurvey Research Methods1864-33612020-06-0114210.18148/srm/2020.v14i2.7757Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United StatesAlicia Frasier0Heidi Guyer1Laura DiGrande2Rose Domanico3Darryl Cooney4Stephanie Eckman5RTI InternationalRTI InternationalRTI InternationalRTI InternationalRTI InternationalRTI International Although counts of the novel Coronavirus (SARS-CoV-2) infections and deaths are reported by several sources online, precise estimation of the exposed proportion of the population is not possible in most areas of the world. Estimates of other disease prevalence in the United States are often obtained through in-person seroprevalence surveys. The availability of testing only for individuals with symptoms, combined with stay-at-home and social distancing mandates to stem the spread of the disease, limit in-person data collection options. A probability-based mail survey with at-home, self-administered testing is a feasible method to safely estimate SARS-CoV-2 antibody prevalence within the United States while also easing burden on the U.S. public and health care system. This mail survey could be a one-time, cross-sectional design, or a repeated cross-sectional or longitudinal survey. We discuss several options for designing and conducting this survey. https://ojs.ub.uni-konstanz.de/srm/article/view/7757COVID-19prevalence surveyMailed data collectionSelf-administered at-home testing |
| spellingShingle | Alicia Frasier Heidi Guyer Laura DiGrande Rose Domanico Darryl Cooney Stephanie Eckman Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States Survey Research Methods COVID-19 prevalence survey Mailed data collection Self-administered at-home testing |
| title | Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States |
| title_full | Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States |
| title_fullStr | Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States |
| title_full_unstemmed | Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States |
| title_short | Design for a Mail Survey to Determine Prevalence of SARS-CoV-2 (COVID-19) Antibodies in the United States |
| title_sort | design for a mail survey to determine prevalence of sars cov 2 covid 19 antibodies in the united states |
| topic | COVID-19 prevalence survey Mailed data collection Self-administered at-home testing |
| url | https://ojs.ub.uni-konstanz.de/srm/article/view/7757 |
| work_keys_str_mv | AT aliciafrasier designforamailsurveytodetermineprevalenceofsarscov2covid19antibodiesintheunitedstates AT heidiguyer designforamailsurveytodetermineprevalenceofsarscov2covid19antibodiesintheunitedstates AT lauradigrande designforamailsurveytodetermineprevalenceofsarscov2covid19antibodiesintheunitedstates AT rosedomanico designforamailsurveytodetermineprevalenceofsarscov2covid19antibodiesintheunitedstates AT darrylcooney designforamailsurveytodetermineprevalenceofsarscov2covid19antibodiesintheunitedstates AT stephanieeckman designforamailsurveytodetermineprevalenceofsarscov2covid19antibodiesintheunitedstates |